CytoArm｜BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment

Company

CytoArm｜BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment

Biotechnology Research 台北市台北市, Tw 9 employees

Employees: 9

www.cytoarm.com LinkedIn

CytoArm｜BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment Overview

Headquarters: 台北市台北市, Tw
Website: www.cytoarm.com
Industry: Biotechnology Research
Employees: 9
Founded: 2020
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

cancer treatment Autologous Cell Therapy Armed-T cell bispecific antibody Immunotherapy T-Cells cell therapy

About CytoArm｜BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment

CytoArm, founded in 2020, focus on untreatable diseases through next generation T cell therapy, Armed-T cell. We are led by experts in both business & medical area, with comprehansive experience to develop novel T cell therapy in clinical treatment

CytoArm｜BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment Contact Details

People in AeroLeads: 4

CytoArm｜BsAb Armed-T Therapy Platform Revolutionizing T Cell Cancer Treatment Org Chart

Sample employees and titles

Name	Title	Location	Contact
Yvette Chen	Msl in Gi - Phd - Immunotherapy		View
Gary Lin	臨床經理 (Clinical Manager)	New Taipei City, Taiwan, Province of China	View
Ting-Yu Chen	Director	Taipei, Taipei City, Taiwan, Province of China	View
Kuo-Hsiang Chuang	Chief Executive Officer at Cytoarm Co.	Taipei, Taipei City, Taiwan, Province of China	View